A data-driven computational model for obesity-driven diabetes onset and remission through weight loss

被引:2
作者
Yildirim, Vehpi [1 ,2 ]
Sheraton, Vivek M. [2 ,3 ,4 ]
Brands, Ruud [5 ,6 ]
Crielaard, Loes [1 ,2 ]
Quax, Rick [2 ,3 ]
van Riel, Natal A. W. [7 ,8 ]
Stronks, Karien [1 ,2 ]
Nicolaou, Mary [1 ,2 ]
Sloot, Peter M. A. [2 ,3 ]
机构
[1] Univ Amsterdam, Amsterdam Univ, Dept Publ & Occupat Hlth, Med Ctr, NL-1081 BT Amsterdam, Netherlands
[2] Univ Amsterdam, Inst Adv Study, NL-1012 GC Amsterdam, Netherlands
[3] Univ Amsterdam, Computat Sci Lab, NL-1098 XH Amsterdam, Netherlands
[4] Univ Amsterdam, Ctr Expt & Mol Med, Acad Med Ctr, Med Ctr, NL-1100 DD Amsterdam, Netherlands
[5] AMRIF BV, Agro Business Pk, NL-6708 PW Wageningen, Netherlands
[6] Univ Utrecht, Inst Risk Assessment Sci, NL-3584 CL Utrecht, Netherlands
[7] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands
[8] Univ Amsterdam, Dept Expt & Vasc Med, Med Ctr, NL-1100 DD Amsterdam, Netherlands
关键词
BETA-CELL MASS; FREE FATTY-ACID; INDUCED INSULIN-RESISTANCE; Y GASTRIC BYPASS; ECTOPIC FAT; GLUCOSE-TOLERANCE; BARIATRIC SURGERY; EARLY IMPROVEMENT; INFLAMMATION; RISK;
D O I
10.1016/j.isci.2023.108324
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Obesity is a major risk factor for the development of type 2 diabetes (T2D), where a sustained weight loss may result in T2D remission in individuals with obesity. To design effective and feasible intervention strategies to prevent or reverse T2D, it is imperative to study the progression of T2D and remission together. Unfortunately, this is not possible through experimental and observational studies. To address this issue, we introduce a data-driven computational model and use human data to investigate the progression of T2D with obesity and remission through weight loss on the same timeline. We identify thresholds for the emergence of T2D and necessary conditions for remission. We explain why remission is only possible within a window of opportunity and the way that window depends on the progression history of T2D, individual's metabolic state, and calorie restrictions. These findings can help to optimize therapeutic intervention strategies for T2D prevention or treatment.
引用
收藏
页数:25
相关论文
共 106 条
  • [1] 2-year remission of type 2 diabetes and pancreas morphology: a post-hoc analysis of the DiRECT open-label, cluster-randomised trial
    Al-Mrabeh, Ahmad
    Hollingsworth, Kieren G.
    Shaw, James A. M.
    McConnachie, Alex
    Sattar, Naveed
    Lean, Michael E. J.
    Taylor, Roy
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (12) : 939 - 948
  • [2] RELIABILITY OF RATES OF GLUCOSE APPEARANCE INVIVO CALCULATED FROM SINGLE TRACER INJECTIONS
    ALLSOP, JR
    WOLFE, RR
    DISTEPHANO, JJ
    BURKE, JF
    [J]. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1979, 57 (11) : 1267 - 1274
  • [3] Bagust Adrian, 2006, Pharmacoeconomics, V24 Suppl 1, P5
  • [4] Impact of Obesity-Induced Inflammation on Cardiovascular Diseases (CVD)
    Battineni, Gopi
    Sagaro, Getu Gamo
    Chintalapudi, Nalini
    Amenta, Francesco
    Tomassoni, Daniele
    Tayebati, Seyed Khosrow
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (09)
  • [5] Dose-response effect of elevated plasma free fatty acid on insulin signaling
    Belfort, R
    Mandarino, L
    Kashyap, S
    Wirfel, K
    Pratipanawatr, T
    Berria, R
    DeFronzo, RA
    Cusi, K
    [J]. DIABETES, 2005, 54 (06) : 1640 - 1648
  • [6] PHYSIOLOGIC EVALUATION OF FACTORS CONTROLLING GLUCOSE-TOLERANCE IN MAN - MEASUREMENT OF INSULIN SENSITIVITY AND BETA-CELL GLUCOSE SENSITIVITY FROM THE RESPONSE TO INTRAVENOUS GLUCOSE
    BERGMAN, RN
    PHILLIPS, LS
    COBELLI, C
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (06) : 1456 - 1467
  • [7] Metabolically Healthy Obesity
    Blueher, Matthias
    [J]. ENDOCRINE REVIEWS, 2020, 41 (03) : 405 - 420
  • [8] Obesity: global epidemiology and pathogenesis
    Blueher, Matthias
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2019, 15 (05) : 288 - 298
  • [9] A score of low-grade inflammation and risk of mortality: prospective findings from the Moli-sani study
    Bonaccio, Marialaura
    Di Castelnuovo, Augusto
    Pounis, George
    De Curtis, Amalia
    Costanzo, Simona
    Persichillo, Mariarosaria
    Cerletti, Chiara
    Donati, Maria Benedetta
    de Gaetano, Giovanni
    Iacoviello, Licia
    [J]. HAEMATOLOGICA, 2016, 101 (11) : 1434 - 1441
  • [10] Relationship between Proinflammatory Cytokines/Chemokines and Adipokines in Serum of Young Adults with Obesity
    Borges, Maraisa D.
    Franca, Eduardo L.
    Fujimori, Mahmi
    Silva, Silvia M. C.
    de Marchi, Patricia G. F.
    Deluque, Alessandra L.
    Honorio-Franca, Adenilda C.
    de Abreu, Luiz C.
    [J]. ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2018, 18 (03) : 260 - 267